Navigation Links
Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development
Date:12/11/2009

CALGARY, Dec. 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced the appointment of Dr. Alan Warrander to the role of Senior Vice President, Global Licensing and Business Development.

"Dr. Warrander will be responsible for the execution of the global licensing strategy for REOLYSIN(R)," said Dr. Brad Thompson, President and CEO of Oncolytics. "Having reached an agreement on the design of a Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers with the U.S. Food and Drug Administration under the Special Protocol Assessment (SPA) process, and with ongoing Phase 2 studies in multiple indications, we felt it was important to bring this skill set in house."

In his 32-year career, Dr. Warrander has held a number of positions within the biotechnology and pharmaceutical industries. He held a number of progressively senior positions in the pharmaceutical industry, most recently as Director, Global Licensing, AstraZeneca. Dr. Warrander subsequently served as Senior Vice President, Life Sciences at Wood Mackenzie, providing partnering support and advice to a range of clients on licensing, merger and acquisition and financing projects globally. Most recently, as an independent consultant, he has worked with a number of biotechnology clients including Oncolytics, serving as a director of Oncolytics Biotech (Barbados) Inc. He holds a PhD from the Department of Biochemistry at the University of Birmingham and a BSc in Chemistry and Biochemistry from the University of St. Andrews.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeu
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters Over-Allotment Option
2. Oncolytics Biotech(R) Inc. Announces Unit Offering
3. Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting
4. Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting
5. Oncolytics(R) Biotech Inc. Announces Issuance of 33rd U.S. Patent
6. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2009
7. Oncolytics Biotech(R) Inc. Announces Investment in Private Biotechnology Company
8. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering Europe
9. Oncolytics Biotech(R) Inc. Accelerates Warrant Expiry Date
10. Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement with the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
11. Oncolytics Biotech(R) Inc. Announces Phase 3 Update Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Md. , May 4, 2015   Intrexon ... will release first quarter 2015 financial results after the ... host a conference call that day at 5:30 PM ... business update. The conference call may be ... and asking to join the "Intrexon Conference Call."  Participants ...
(Date:5/1/2015)... Md. , May 1, 2015  Northwest Biotherapeutics ... company developing DCVax® personalized immune therapies for solid tumor ... the $28.5 million second tranche of a $40 million ... Woodford first invested $25 million in NW ... Woodford entered into an agreement with the Company for ...
(Date:5/1/2015)... SAN DIEGO , May 1, 2015 /PRNewswire/ ... biotechnology company engaged in the development of biosimilar ... proteins, announced today that its first quarter 2015 ... 14, 2015, before the open of market. At 8:30 ... conference call to discuss the financial results and ...
(Date:5/1/2015)... May 1, 2015 Investor-Edge ... Technologies Ltd (NASDAQ: GENE ), Agilent Technologies ... Inc. (NYSE: TMO ), Sequenom Inc. (NASDAQ: ... PKI ). Free research report on Genetic Technologies ... Thursday, April 30, 2015, the NASDAQ Composite ended ...
Breaking Biology Technology:Intrexon to Announce First Quarter 2015 Financial Results on Monday, May 11, 2015 2NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 2NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 3Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 2Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 3Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 4Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 5
... Calif., June 18 ,Exelixis, Inc. (Nasdaq: EXEL ) ... financial officer at Exelixis, will present at the,Piper Jaffray ... UK time on Wednesday, June 25, 2008. Mr. Karbe ... strategy., The presentation will be webcast and may ...
... is on the,cutting edge in biotechnology R&D and is ... in Germany are poised to,profit from the latest developments ... at the BIO International Convention (BIO 2008),in San Diego, ... along with the CEO of a major transatlantic biotech ...
... Company Accelerates Next Generation Cellulosic Feedstock Program, ... Performance Plants Inc. (PPI) has,announced today that ... to,develop specialized non-food crops for industries seeking ... coal,replacement., The facility, located in Waterloo, ...
Cached Biology Technology:BIO 2008: Germany on Cutting Edge in Biomanufacturing 2Performance Plants Establishes U.S. Biofuels Facility 2
(Date:4/1/2015)... 1, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces the second ... is underway to early access pre-order customers. ... at retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, ... was accepted at all outlets and very easy to ...
(Date:3/26/2015)... March 26, 2015 The Granite ... recreation and athletic club, today announced it has implemented ... freedom of movement for members and staff, while restricting ... comprehensive process, we selected FST,s IMID Access system because ... for our members and staff, in addition to unparalleled ...
(Date:3/23/2015)... SoundView Technology Group issues a new research update following the ... wallet. SoundView was one of the selected user groups to provide ... in multiple scenarios and outlets. Soundview shares ... both debit and credit card payments.  Soundview ... meets their plans in 2015, it would push our IV ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4
... leaf often catches a poet,s eye, but scientists also ... or abscission in plants. Abscission is the physiological process ... petals, flowers and fruit, that allow plants to discard ... uncovered the genetic pathway that controls abscission in the ...
... ANN ARBOR, Mich.---A glitch in the ability to move ... as Type IV mucolipidosis (ML4) and the suite of ... it, new research at the University of Michigan shows. ... in aging and neurodegenerative diseases such as Alzheimer,s and ...
... Aspirin has become one of the most widely used ... reduce pain, fevers, inflammation, and blood clotting. In animal ... though none of its known mechanisms of action would ... though, researchers have uncovered the mechanism that may explain ...
Cached Biology News:When leaves fall, more is occurring than a change of weather 2Iron-moving malfunction may underlie neurodegenerative diseases, aging 2Iron-moving malfunction may underlie neurodegenerative diseases, aging 3
... Xcise is a powerful technology platform that ... analysis. High quality sample preparation can ... , The Xcise is a powerful technology ... throughput proteome analysis. It combines the functions ...
CQCS kit for first KR 4i , (first unit)....
... lower consumption of reagents and increased ... Multidrop 384 is an automated dispenser ... dispensing into 384- and 96-well plates.This ... can easily switch from 96- to ...
Wellpro 96 an automated liquid handling system for 96-well plates that quickly and accurately prepares large quantities of serial dilutions. The Wellpro also performs plate to plate transfers using ...
Biology Products: